Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Background The use of thrombolytic agents in the treatment of hemodynamically stable
patients with acute submassive pulmonary embolism remains controversial. Methods We …

Background— Assessment of risk and appropriate management of patients with acute
pulmonary embolism (PE) remains a challenge. Cardiac troponins I (cTnI) and T (cTnT) are …

determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the individual …

Guidelines on the diagnosis and management of acute pulmonary embolism | European
Heart Journal | Oxford Academic Skip to Main Content Advertisement intended for healthcare …

Background The role of fibrinolytic therapy in patients with intermediate-risk pulmonary
embolism is controversial. Methods In a randomized, double-blind trial, we compared …

Background— Thrombosis is the common pathology underlying ischemic heart disease,
ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study …

Objectives. The present study investigated current management strategies as well as the
clinical course of acute major pulmonary embolism. Background. The clinical outcome of …

Background Thrombolytic treatment has been shown to accelerate resolution of major pulmonary
embolism and lead to a rapid improvement of right-side hemodynamics. However, the …